logo
Select company
Select metric
$ -11.47MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
24
Sector
59
Industry
45
History
82
$ 11.54Close
$ 2.43 - $ 11.92 52-Week Range
Ticker Information

Ticker

XGN

Company Name

EXAGEN INC

Sector

Healthcare

Industry

Diagnostics & Research

Exchange

NASDAQ

EXAGEN INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

XGN - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 2.67M$ -14.14M$ -11.47M
3/31/2025$ 2.61M$ -13.27M$ -10.65M
12/31/2024$ 2.61M$ -12.87M$ -10.26M
9/30/2024$ 2.69M$ -14.66M$ -11.96M
6/30/2024$ 2.9M$ -15.05M$ -12.15M
3/31/2024$ 2.99M$ -17.08M$ -14.09M
12/31/2023$ 3.11M$ -21.32M$ -18.21M
9/30/2023$ 3.13M$ -30.36M$ -27.23M
6/30/2023$ 2.94M$ -32.98M$ -30.04M
3/31/2023$ 2.81M$ -42.6M$ -39.79M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • EXAGEN INC's latest trailing twelve months (TTM) EBITDA stands at $ -13.55M.
  • Over the past 5 years, EXAGEN INC's average EBITDA has been $ -21.28M.
  • The median EBITDA for EXAGEN INC during this period was $ -17.62M
  • EXAGEN INC reached its highest EBITDA over the past 5 years at $ -10.26M.
  • The lowest EBITDA recorded by EXAGEN INC in the same timeframe $ -42.7M

EXAGEN INC's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
CVRX : CVRX INC $ -46.15MELMD : ELECTROMED INC $ 11.32MDERM : JOURNEY MEDICAL CORP $ -1.19MLNSR : LENSAR INC $ -44.48MACRS : ACLARIS THERAPEUTICS INC $ -134.09MENTA : ENANTA PHARMACEUTICALS INC $ -82.41MMASS : 908 DEVICES INC $ -13.4MTHTX : THERATECHNOLOGIES INC $ 7.31MSGHT : SIGHT SCIENCES INC $ -42.69MPDEX : PRO DEX INC $ 14.13M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for EXAGEN INC is calculated as follows: EBIT [ $ -14.05M ] + DepAmor [ $ 503K ]
(=) EBITDA [ $ -13.55M ]

XGN - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -42.7M

Minimum

Dec 31, 2022

$ -10.26M

Maximum

Dec 31, 2024

$ -21.28M

Average

$ -17.62M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.79M with a standard deviation of $ 166.94M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.25K
min$ -493.3M
max$ 590.6M
average$ 58.79M
median$ 8.83M
std$ 166.94M